Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 316 results for "sun pharmaceutical industries"

Indian pharmaceutical sector may take a hit under Trump regime
Oneindia

At Press Conference, Trump Raises Issue of Pharma Overcharging...

NEW YORK (IANS) —In his first media conference as president-elect, Donald Trump, without naming any country in particular, laid bare his views on the U.S. pharmaceutical sector, as well as on the loss of American jobs in manufacturing, both of ... India-West, 3 days ago
[x]  

50 images for sun pharmaceutical industries

Investing.com, 2 weeks ago
New Indian Express, 3 weeks ago
Livemint.com, 1 month ago
foxnews.com, 1 month ago
Yahoo! News, 1 month ago
Yahoo! UK and Ireland, 1 month ago
Reuters, 1 month ago
Deccan Chronicle, 3 weeks ago
Financial Express, 1 week ago
Pharmaceutical Tech.com, 1 week ago
India Infoline

Sun Pharma rise nearly 2% on successful trial for Seciera

The article below represents a preview only and is not meant for reuse or republishing. India, Jan. 5 -- Shares of Sun Pharmaceutical Industries advanced nearly 2 per cent in early trade on the Bombay Stock Exchange after the drug maker announces ...
 HT Syndication1 week ago Sun Pharma announces results of clinical trials for Seciera  HT Syndication1 week ago Sun Pharma gains after successful clinical trial results of ophthalmic solution  Business Standard1 week ago Sun Pharma may gain after successful clinical trial of ophthalmic solution  Business Standard1 week ago
[x]  
India Infoline

Stock to watch out for today: Sun Pharma

Pharma sector could well be the sector to watch out for in 2017. The performance of Sun Pharma will be keenly watched as it is one of the largest Indian Pharmaceutical companies both in terms of market capitalisation and turnover that manufactures ...
 India Infoline3 days ago

No scope of US intervention in Indian pharma cos: Wockhardt

Wockhardt chief says that Indian generic company as a whole is a competitive industry in US and therefore there is no scope for government intervention there. Anmol Ganjoo of JM Financial says if drug prices come down then Indian pharma companies ...
 Moneycontrol.com4 days ago

Aurobindo strengthens its presence in Europe

Aurobindo Pharma announced yet another acquisition in Europe, as it signed a binding agreement to acquire Portuguese drug firm Genesis for 135 million euro (Rs 969 crore). Aurobindo has been steadily expanding its European footprint since 2006 and ...
 Smart Investor1 week ago Sun Pharma to acquire US-based Ocular Technologies  Prokerala2 months ago Sun Pharmaceutical to acquire 100% equity stake of Ocular Technologies  Money Control2 months ago Sun Pharma To Acquire U.S.-Based Ocular Technologies  Silicon India2 months ago
Financial Express

Morgan Stanley rates Sun Pharmaceutical Industries Equal-Weight

Sun continues to bolster its specialty pipeline—Tildrakizumab (Merck), Odomzo (Novartis), MM-II (Moebius), Seciera (Ocular), Elepsia/Xelpros (SPARC), BromSite/DexaSite (Insite), Absorica (Ranbaxy), and Dusa drug products. Sun announced that its ...
 Financial Express1 week ago
Pharmaceutical Tech.com

India's Sun Pharma reports positive topline results of phase-3 clinical trial for Seciera

Sun Pharmaceutical Industries Ltd announces positive topline results of confirmatory phase-3 clinical trial for Seciera for treatment of dry eye. Says Seciera meets primary and key secondary endpoints in pivotal trial. Says Seciera shows efficacy ...
 Pharmaceutical Tech.com1 week ago Sun Pharma Announces Positive Topline Results of Confirmatory Phase-3 Clinical Trial for Seciera for Treatment of Dry Eye  PipelineReview1 week ago Sun Pharmaceutical Industries : Pharma Announces Positive Topline Results of Confirmatory Phase-3 Clinical Trial for Seciera for Treatment of Dry Eye  4 Traders1 week ago Sun Pharma unit asks US FDA to withdraw nod for 28 drug applications of Ranbaxy  Money Today3 weeks ago
[x]  
Livemint.com

Opening bell: Asian markets open mixed; Fortis Healthcare, SBI, Sun Pharma in news

In other news, global private equity fund KKR & Co. Lp is in talks with the Singh brothers to acquire a controlling stake in hospital chain Fortis Healthcare Ltd US market ends higher; Asia opens mixed US stocks closed higher on Wednesday, as ...
 Livemint.com1 week ago Opening bell: Asian markets open lower; Sun Pharma, Suzlon Energy, UBHL in news  Livemint.com3 weeks ago Opening bell: Global equities rise ahead of US Fed decision; Sun Pharma in news  Livemint.com1 month ago

Sun Pharma inches up on the BSE

India, Jan. 6 -- Sun Pharmaceutical Industries is currently trading at Rs. 643.75, up by 0.50 points or 0.08% from its previous closing of Rs. 643.25 on the BSE.The scrip opened at Rs. 650.00 and has touched a high and low of Rs. 650.00 and Rs.
 HT Syndication1 week ago Sun Pharma advances with arm acquiring 14.58% stake in scPharmaceuticals  HT Syndication3 weeks ago

Pharma cos need to realign biz models

Pharma companies should focus on high-performing therapeutic area and geographic markets and they need to realign their business models to be able to cope up going forward in 2017-18, writes Amit Varma , Managing Partner, Quadria Capital Amit ...
 Express Pharma1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less